Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

G. Brobert; R. L. Garcia; E. Garbe; I. D. Bezemer; D. Layton; L. Friberg; K. Suzart-Woischnik; J. Alderson; C. Winchester; R. M. Herings; K. Jobski; T. Schink; S. Shakir; M. Soriano-Gabarro; M. A. Wallander

doi:https://doi.org/10.1016/j.jval.2014.08.1350

Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

G. Brobert, R. L. Garcia, E. Garbe, I. D. Bezemer, D. Layton, L. Friberg, K. Suzart-Woischnik, J. Alderson, C. Winchester, R. M. Herings, K. Jobski, T. Schink, S. Shakir, M. Soriano-Gabarro, M. A. Wallander

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	A473-4
Journal	Value in health
Volume	17
Issue number	7
DOIs	https://doi.org/10.1016/j.jval.2014.08.1350
Publication status	Published - 2014
Externally published	Yes

Access to Document

https://doi.org/10.1016/j.jval.2014.08.1350

https://www.ncbi.nlm.nih.gov/pubmed/27201360

Cite this

Brobert, G., Garcia, R. L., Garbe, E., Bezemer, I. D., Layton, D., Friberg, L., Suzart-Woischnik, K., Alderson, J., Winchester, C., Herings, R. M., Jobski, K., Schink, T., Shakir, S., Soriano-Gabarro, M., & Wallander, M. A. (2014). Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice. Value in health, 17(7), A473-4. https://doi.org/10.1016/j.jval.2014.08.1350

@article{137aca74d14b494d8f1dec647a70260d,

title = "Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice",

author = "G. Brobert and Garcia, {R. L.} and E. Garbe and Bezemer, {I. D.} and D. Layton and L. Friberg and K. Suzart-Woischnik and J. Alderson and C. Winchester and Herings, {R. M.} and K. Jobski and T. Schink and S. Shakir and M. Soriano-Gabarro and Wallander, {M. A.}",

note = "Brobert, G Garcia, Rodriguez L A Garbe, E Bezemer, I D Layton, D Friberg, L Suzart-Woischnik, K Alderson, J Winchester, C Herings, R M C Jobski, K Schink, T Shakir, S Soriano-Gabarro, M Wallander, M A eng Value Health. 2014 Nov;17(7):A473-4. doi: 10.1016/j.jval.2014.08.1350. Epub 2014 Oct 26.",

year = "2014",

doi = "https://doi.org/10.1016/j.jval.2014.08.1350",

language = "English",

volume = "17",

pages = "A473--4",

journal = "Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research",

issn = "1524-4733",

publisher = "Elsevier Limited",

number = "7",

}

Brobert, G, Garcia, RL, Garbe, E, Bezemer, ID, Layton, D, Friberg, L, Suzart-Woischnik, K, Alderson, J, Winchester, C, Herings, RM, Jobski, K, Schink, T, Shakir, S, Soriano-Gabarro, M & Wallander, MA 2014, 'Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice', Value in health, vol. 17, no. 7, pp. A473-4. https://doi.org/10.1016/j.jval.2014.08.1350

TY - JOUR

T1 - Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice

AU - Brobert, G.

AU - Garcia, R. L.

AU - Garbe, E.

AU - Bezemer, I. D.

AU - Layton, D.

AU - Friberg, L.

AU - Suzart-Woischnik, K.

AU - Alderson, J.

AU - Winchester, C.

AU - Herings, R. M.

AU - Jobski, K.

AU - Schink, T.

AU - Shakir, S.

AU - Soriano-Gabarro, M.

AU - Wallander, M. A.

N1 - Brobert, G Garcia, Rodriguez L A Garbe, E Bezemer, I D Layton, D Friberg, L Suzart-Woischnik, K Alderson, J Winchester, C Herings, R M C Jobski, K Schink, T Shakir, S Soriano-Gabarro, M Wallander, M A eng Value Health. 2014 Nov;17(7):A473-4. doi: 10.1016/j.jval.2014.08.1350. Epub 2014 Oct 26.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1016/j.jval.2014.08.1350

DO - https://doi.org/10.1016/j.jval.2014.08.1350

M3 - Article

SN - 1524-4733

VL - 17

SP - A473-4

JO - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

JF - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

IS - 7

ER -